Clinical data | |
---|---|
AHFS/Drugs.com | Monograph |
MedlinePlus | a601102 |
Pregnancy category |
|
Routes of administration |
Oral, Nasal, Rectal, Injection, IV |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 70% |
Metabolism | prednisolone (liver) |
Biological half-life | 18 to 36 hours. |
Excretion | Renal |
Identifiers | |
|
|
Synonyms | Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone, Prednisonum |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard | 100.000.147 |
Chemical and physical data | |
Formula | C21H26O5 |
Molar mass | 358.428 g/mol |
3D model (Jmol) | |
|
|
|
|
(what is this?) |
Prednisone is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant drug. It is used to treat certain inflammatory diseases (such as moderate allergic reactions), some autoimmune diseases, and (at higher doses) some types of cancer, but it has significant adverse effects.
Prednisone is used, at a usual adult dosage of 5–60 mg/day, for many different indications including: asthma, COPD, CIDP, rheumatic disorders, allergic disorders, ulcerative colitis and Crohn's disease, adrenocortical insufficiency, hypercalcemia due to cancer, thyroiditis, laryngitis, severe tuberculosis, urticaria (hives), lipid pneumonitis, pericarditis, multiple sclerosis, nephrotic syndrome, to relieve the effects of shingles, lupus, myasthenia gravis, poison oak exposure, Ménière's disease, and as part of a drug regimen to prevent rejection after organ transplant.